anonymous
Guest
anonymous
Guest
company has been coddling oncology for a while. Unfortunately for them there is a major layoff coming. Hope you enjoyed your luxury ride while it lasted. Carousel coming to a stop. Get off!!!!
”Coddling”? You must be joking?company has been coddling oncology for a while. Unfortunately for them there is a major layoff coming. Hope you enjoyed your luxury ride while it lasted. Carousel coming to a stop. Get off!!!!
upper management will have some bad news soon. Merry christmasThey just hired a bunch of reps how can there be layoffs already? Great Lakes has pretty much a brand new team. What about the upcoming hcc indication? I don’t think this is correct.
Something is definitely going on in WCL. I can’t say it’ll be a layoff announcement or not, but, some type of shakeup for sure.upper management will have some bad news soon. Merry christmas
Over 50% of the US oncology division revenue comes from a drug going generic in 2018. Eisai hasn’t secured new indications or bought a new drug to replace that revenue. Doesn’t take a rocket scientist to realize the lights can’t stay on the way things are in a couple months.
Not true.! Hepatocullular is coming soon and it’s not a huge indication but Im excited about it! It something new and it will help patients. That is why I am in this industry and there are a whole bunch of things to be angry about. I get that.
Ha! “A day late and a dollar short” should be Eisai’s corporate motto.So naive. You do realize Opdivo got FDA accelerated approval granted Sept 2017. Good luck selling Lenvima over Opdivo. Worse clinical data and costs significantly more than Opdivo. Eisai is a day late and a dollar short in HCC too.
Not true.! Hepatocullular is coming soon and it’s not a huge indication but Im excited about it! It something new and it will help patients. That is why I am in this industry and there are a whole bunch of things to be angry about. I get that.
If you work at Eisai now, it would be a good idea to have a plan B. Most likely a 10-20% reduction in sales force but not likely to be announced until February and to take effect in April.LOL!